Table 1 Clinical characteristics and metabolic parameters of male subjects with type-2 diabetes, pre-diabetes and no diabetes
From: Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic Saudis
| Â | No Diabetes | Pre-diabetes | Type-2 Diabetes |
|---|---|---|---|
N | 45 | 49 | 97 |
Age (years) | 45.7(12.6) | 50.1(11.6) | 54.5(10.7)f |
Systolic blood pressure (mm Hg) | 123.1(16.9) | 132.8(25.1)a | 130.7(17.5) |
Diastolic blood pressure (mm Hg) | 79.9(9.1) | 85.1(11.4) | 82.9(10.5) |
BMI (Kg/m2) | 29.2(7.3) | 28.5(4.3) | 27.3(4.1) |
Waist (cm) | 93.7(18.2) | 98.6(10.1) | 96.4(15.1) |
Hips (cm) | 95.9(15.7) | 100.5(13.9) | 99.8(14.4) |
Fasting Glucose (mmol/L) | 4.8(0.6) | 6.1(0.4)f | 13.7(5.0)f |
Cholesterol (mmol/L) | 5.2(1.6) | 5.6(1.4) | 6.5(1.9)f |
HDL (mmol/L) | 0.94(0.3) | 1.2(0.4) | 0.9(0.4) |
Triglyceride (mmol/L) | 1.8(0.6–6.7) | 1.9(0.7–6.3) | 2.5(1.6–15) |
LDL (mmol/L) | 3.3(1.1) | 3.9(1.6) | 4.2(1.8)b |
Insulin μmol/L * | 12.6(2–99) | 12.3 (2–36) | 16.2(2–70) |
Leptin ng/mL * | 3.9(0.8–20) | 7.6(1.2–72)d | 12.4(3.2–72)c |
APO A1 mg/dL | 0.9(0.3) | 0.9(0.5) | 0.9(0.3) |
APO A2 mg/dL | 0.4(0.1) | 0.4(0.1) | 0.3(0.1) |
HOMA-IR * | 3.3(0.3–23.8) | 3.5(0.5–10.2) | 9.6(1.1–49.7)e |